Cord Blood News Volume 7.15 | Apr 23 2015

    0
    111

    Cord Blood News 7.15 April 23, 2015

    Cord Blood News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook   CBN on Twitter

     
    TOP STORY
    Comparison of Outcomes after Unrelated Cord Blood and Unmanipulated Haploidentical Stem Cell Transplantation in Adults with Acute Leukemia
    Investigators compared outcomes after unrelated cord blood transplantation and haploidentical stem cell transplantation in adults with de novo acute myeloid leukemia and acute lymphoblastic leukemia. [Leukemia] Abstract
    Enter to Win a Travel Support Award to ISSCR2015!

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    Molecular and Phenotypic Characterization of CD133 and SSEA4 Enriched Very Small Embryonic-Like Stem Cells in Human Cord Blood
    Researchers describe enrichment strategy and molecular and phenotypic characterization of human cord blood embryonic-like stem cells (VSELs). Flow cytometry analysis revealed that majority of VSELs were present in the red blood cells pellet after Ficoll-Hypaque centrifugation in contrast to the hematopoietic stem cells in the interphase layer. [Leukemia] Abstract

    Hair Regrowth in Alopecia Areata Patients following Stem Cell Educator Therapy
    Scientists developed a stem cell educator therapy in which a patient’s blood is circulated through a closed-loop system that separates mononuclear cells from the whole blood, allowing the cells to briefly interact with adherent human cord blood-derived multipotent stem cells, and returning the “educated” autologous cells to the patient’s circulation. [BMC Med] Abstract | Full Article

    Proteomic Analysis of Porcine Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord: Implication of the Proteins Involved in the Higher Migration Capability of Bone Marrow Mesenchymal Stem Cells
    Porcine bone marrow mesenchymal stem cells (MSCs) and umbilical cord MSCs were evaluated with flow cytometric and adipogenic and osteogenic differentiation analyses. [Stem Cell Res Ther] Abstract | Full Article

    Umbilical Cord Mesenchymal Stem Cells Modulate Dextran Sulphate Sodium Induced Acute Colitis in Immunodeficient Mice
    Scientists examined the protective potential of exogenously administered human umbilical cord derived mesenchymal stem cells against dextran sulphate sodium induced acute colitis in immunodeficient NOD.CB17-Prkdc scid/J mice with particular attention to endoplasmic reticulum stress. [Stem Cell Res Ther]
    Abstract | Full Article

    Role of Hepatocyte Growth Factor in the Immunomodulation Potential of Amniotic Fluid Stem Cells
    Researchers found that hepatocyte growth factor produced by human amniotic fluid stem cells exerts a cytoprotective role, inducing an increase in caspase-dependent apoptosis in human immune cells. [Stem Cells Transl Med] Abstract

    Human Umbilical Cord-Derived Mesenchymal Stem Cells Improve Learning and Memory Function in Hypoxic-Ischemic Brain-Damaged Rats via an IL-8-Mediated Secretion Mechanism Rather than Differentiation Pattern Induction
    Based on flow cytometry analysis, human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) exhibited the morphological characteristics and surface markers of MSCs. All types of hUC-MSCs, including differentiated and redifferentiated cells, promoted learning and memory function recovery in hypoxic-ischemic brain damaged rats. [Cell Physiol Biochem] Full Article

    GFP Labeling and Hepatic Differentiation Potential of Human Placenta-Derived Mesenchymal Stem Cells
    Scientists established human placenta-derived mesenchymal stem cells (hPMSCs) expressing green fluorescent protein and assayed their hepatic functional differentiation in vitro. The green fluorescent protein (GFP) gene was transduced into hPMSCs using a lentivirus to establish GFP+ hPMSCs. [Cell Physiol Biochem] Full Article

    Characteristics of Human Amniotic Fluid Mesenchymal Stem Cells and Their Tropism to Human Ovarian Cancer
    Investigators obtained and characterized human amniotic fluid mesenchymal stem cells (AFMSCs) and detected their ovarian cancer tropsim in nude mice model. AFMSCs presented a fibroblastic-like morphology during the culture. [PLoS One] Full Article

    Efficacy and Safety of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Anterior Cruciate Ligament Reconstruction of a Rabbit Model: New Strategy to Enhance Tendon Graft Healing
    Researchers investigated whether non-autologous transplantation of human umbilical cord blood-derived mesenchymal stem cells could be integrated safely at the bone-tendon junction without immune rejection and could enhance bone-tendon healing effectively during anterior cruciate ligament reconstruction in an animal model. [Arthroscopy] Abstract

    Get More of the Cells You Need with StemSpanâ„¢ Megakaryocyte Expansion Supplement and StemSpanâ„¢ SFEM

     
    REVIEWS
    Allogeneic Stem Cell Transplantation in Multiple Myeloma: Immunotherapy and New Drugs
    The authors examine the current evidence for the use of allogeneic stem cell transplantation in multiple myeloma. They review novel cell therapies that may be exploited to induce myeloma-specific immune responses including the new promising frontier of chimeric antigen receptor-T and -natural killer cells. [Expert Opin Biol Ther] Abstract

    Visit our reviews page to see a complete list of reviews in the cord blood research field.

    Your Favorite Immunology Newsletters Are Now on Facebook! Like Us Today!

     
    INDUSTRY NEWS
    Targazyme, Inc. and M.D. Anderson Cancer Center Receive FDA IND Clearance for Phase I/II Study of TZ101-Treated Regulatory T Cells to Prevent Graft vs. Host Disease in Patients Eligible for Hematologic Stem Cell Transplantation
    Targazyme Inc. announced that the U.S. Food and Drug Administration (FDA) has granted IND Clearance to M.D. Anderson Cancer Center to start enrolling patients in a Phase I/II clinical study to evaluate the safety and efficacy of TZ101-fucosylated regulatory T cells in preventing and reducing the severity and incidence of graft vs. host disease in patients eligible for hematologic stem cell transplant. [Targazyme Inc.] Press Release

    Actinium Doses the First Patient in the Fourth, Final Cohort of Its Actimab-A Trial
    Actinium Pharmaceuticals, Inc. announced that the first patient was successfully treated with Actimab-A drug candidate in the fourth and last cohort of the ongoing Phase I/II trial of Actimab-A. Actimab-A is being developed for newly diagnosed AML patients over the age of 60 ineligible for standard induction chemotherapy. [Actinium Pharmaceuticals, Inc.] Press Release

    From our sponsor: Studying ESCs or iPSCs? Request your free copy of the small molecules wallchart.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Stem Cells & Regenerative Medicine Congress USA
    September 2-3, 2015
    Washington D.C., United States

    Visit our events page to see a complete list of events in the cord blood community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Associate – Epigenetic Regulation of Normal and Leukemic Stem Cells (Sanford-Burnham Medical Research Institute)

    Principal Scientist – Hematopoietic Products (STEMCELL Technologies Inc.)

    Research Associate – Cell Separation (STEMCELL Technologies Inc.)

    Postdoctoral Fellow – Stem Cell Trans Regulation (BloodCenter of Wisconsin)

    Postdoctoral Fellow – Hematopoietic Stem Cell Biology (University of Leuven)

    Postdoctoral Fellow – Hematopoietic Stem Cell Research (Lund University)

    Postdoctoral Research Fellow – Stem Cell/Hematopoiesis Research (BloodCenter of Wisconsin)

    Research Associate – Hematopoietic and Leukemic Stem Cells (Shanghai Jiao-Tong University School of Medicine)

    Postdoctoral Fellows – Leukemia Research and Stem Cell Biology (Josep Carreras Leukemia Research Institute)

    PhD Studentships – Expansion of Umbilical Cord Blood Stem Cells (University College London)

    Cord Tissue Processing Technician (Cord Blood Registry)

    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Cord Blood News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Cord Blood News: Archives | Events | Contact Us